Publication
Clinical Impact of Albumin-Bilirubin (ALBI) Score in Patients With Recurrent Esophageal Cancer After Curative Treatment.
Taiichi Kawabe, Toru Aoyama, Itaru Hashimoto, Yukio Maezawa, Sho Sato, Takashi Kosaka, Miki Kayashima, Maki Takagi, Kohei Sekiguchi, Kiyoko Shimada, Naoko Okuda, Momoko Fukuda, Masaki Takahashi, Mihwa Ju, Natsumi Kamiya, Yosuke Atsumi, Keisuke Kazama, Nobuhiro Sugano, Ayako Tamagawa, Aya Saito, Takaki Yoshikawa, Norio Yukawa
- Source
- PubMed
- Retrieved
- Sep 16, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260916-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
BACKGROUND/AIM: The albumin-bilirubin (ALBI) score, which evaluates pretreatment liver function, has been reported as a prognostic factor in several malignancies. We conducted a retrospective study to clarify the prognostic impact of the ALBI score in patients with recurrent esophageal…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerMalignant Esophageal Neoplasmdictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available